
The global Antimicrobial Susceptibility Testing Device market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
The “Antimicrobial Susceptibility Testing Device Industry Forecast” looks at past sales and reviews total world Antimicrobial Susceptibility Testing Device sales in 2024, providing a comprehensive analysis by region and market sector of projected Antimicrobial Susceptibility Testing Device sales for 2025 through 2031. With Antimicrobial Susceptibility Testing Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antimicrobial Susceptibility Testing Device industry.
This Insight Report provides a comprehensive analysis of the global Antimicrobial Susceptibility Testing Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antimicrobial Susceptibility Testing Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Antimicrobial Susceptibility Testing Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antimicrobial Susceptibility Testing Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antimicrobial Susceptibility Testing Device.
This report presents a comprehensive overview, market shares, and growth opportunities of Antimicrobial Susceptibility Testing Device market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Agar Dilution Type
Broth Dilution Type
Others
Segmentation by Application:
Pharmaceutical and Biotechnology Companies
Contract Research Organizations
Hospitals
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Q-Linea
Liofilchem
Beckman
Thermo Fisher Scientific
Biomerieux
BD
Bio-Rad
Accelerate Diagnostics, Inc
Alifax
Synbiosis
Key Questions Addressed in this Report
What is the 10-year outlook for the global Antimicrobial Susceptibility Testing Device market?
What factors are driving Antimicrobial Susceptibility Testing Device market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Antimicrobial Susceptibility Testing Device market opportunities vary by end market size?
How does Antimicrobial Susceptibility Testing Device break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Antimicrobial Susceptibility Testing Device Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Antimicrobial Susceptibility Testing Device by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Antimicrobial Susceptibility Testing Device by Country/Region, 2020, 2024 & 2031
2.2 Antimicrobial Susceptibility Testing Device Segment by Type
2.2.1 Agar Dilution Type
2.2.2 Broth Dilution Type
2.2.3 Others
2.3 Antimicrobial Susceptibility Testing Device Sales by Type
2.3.1 Global Antimicrobial Susceptibility Testing Device Sales Market Share by Type (2020-2025)
2.3.2 Global Antimicrobial Susceptibility Testing Device Revenue and Market Share by Type (2020-2025)
2.3.3 Global Antimicrobial Susceptibility Testing Device Sale Price by Type (2020-2025)
2.4 Antimicrobial Susceptibility Testing Device Segment by Application
2.4.1 Pharmaceutical and Biotechnology Companies
2.4.2 Contract Research Organizations
2.4.3 Hospitals
2.4.4 Others
2.5 Antimicrobial Susceptibility Testing Device Sales by Application
2.5.1 Global Antimicrobial Susceptibility Testing Device Sale Market Share by Application (2020-2025)
2.5.2 Global Antimicrobial Susceptibility Testing Device Revenue and Market Share by Application (2020-2025)
2.5.3 Global Antimicrobial Susceptibility Testing Device Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Antimicrobial Susceptibility Testing Device Breakdown Data by Company
3.1.1 Global Antimicrobial Susceptibility Testing Device Annual Sales by Company (2020-2025)
3.1.2 Global Antimicrobial Susceptibility Testing Device Sales Market Share by Company (2020-2025)
3.2 Global Antimicrobial Susceptibility Testing Device Annual Revenue by Company (2020-2025)
3.2.1 Global Antimicrobial Susceptibility Testing Device Revenue by Company (2020-2025)
3.2.2 Global Antimicrobial Susceptibility Testing Device Revenue Market Share by Company (2020-2025)
3.3 Global Antimicrobial Susceptibility Testing Device Sale Price by Company
3.4 Key Manufacturers Antimicrobial Susceptibility Testing Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Antimicrobial Susceptibility Testing Device Product Location Distribution
3.4.2 Players Antimicrobial Susceptibility Testing Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Antimicrobial Susceptibility Testing Device by Geographic Region
4.1 World Historic Antimicrobial Susceptibility Testing Device Market Size by Geographic Region (2020-2025)
4.1.1 Global Antimicrobial Susceptibility Testing Device Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Antimicrobial Susceptibility Testing Device Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Antimicrobial Susceptibility Testing Device Market Size by Country/Region (2020-2025)
4.2.1 Global Antimicrobial Susceptibility Testing Device Annual Sales by Country/Region (2020-2025)
4.2.2 Global Antimicrobial Susceptibility Testing Device Annual Revenue by Country/Region (2020-2025)
4.3 Americas Antimicrobial Susceptibility Testing Device Sales Growth
4.4 APAC Antimicrobial Susceptibility Testing Device Sales Growth
4.5 Europe Antimicrobial Susceptibility Testing Device Sales Growth
4.6 Middle East & Africa Antimicrobial Susceptibility Testing Device Sales Growth
5 Americas
5.1 Americas Antimicrobial Susceptibility Testing Device Sales by Country
5.1.1 Americas Antimicrobial Susceptibility Testing Device Sales by Country (2020-2025)
5.1.2 Americas Antimicrobial Susceptibility Testing Device Revenue by Country (2020-2025)
5.2 Americas Antimicrobial Susceptibility Testing Device Sales by Type (2020-2025)
5.3 Americas Antimicrobial Susceptibility Testing Device Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antimicrobial Susceptibility Testing Device Sales by Region
6.1.1 APAC Antimicrobial Susceptibility Testing Device Sales by Region (2020-2025)
6.1.2 APAC Antimicrobial Susceptibility Testing Device Revenue by Region (2020-2025)
6.2 APAC Antimicrobial Susceptibility Testing Device Sales by Type (2020-2025)
6.3 APAC Antimicrobial Susceptibility Testing Device Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Antimicrobial Susceptibility Testing Device by Country
7.1.1 Europe Antimicrobial Susceptibility Testing Device Sales by Country (2020-2025)
7.1.2 Europe Antimicrobial Susceptibility Testing Device Revenue by Country (2020-2025)
7.2 Europe Antimicrobial Susceptibility Testing Device Sales by Type (2020-2025)
7.3 Europe Antimicrobial Susceptibility Testing Device Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Antimicrobial Susceptibility Testing Device by Country
8.1.1 Middle East & Africa Antimicrobial Susceptibility Testing Device Sales by Country (2020-2025)
8.1.2 Middle East & Africa Antimicrobial Susceptibility Testing Device Revenue by Country (2020-2025)
8.2 Middle East & Africa Antimicrobial Susceptibility Testing Device Sales by Type (2020-2025)
8.3 Middle East & Africa Antimicrobial Susceptibility Testing Device Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Antimicrobial Susceptibility Testing Device
10.3 Manufacturing Process Analysis of Antimicrobial Susceptibility Testing Device
10.4 Industry Chain Structure of Antimicrobial Susceptibility Testing Device
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Antimicrobial Susceptibility Testing Device Distributors
11.3 Antimicrobial Susceptibility Testing Device Customer
12 World Forecast Review for Antimicrobial Susceptibility Testing Device by Geographic Region
12.1 Global Antimicrobial Susceptibility Testing Device Market Size Forecast by Region
12.1.1 Global Antimicrobial Susceptibility Testing Device Forecast by Region (2026-2031)
12.1.2 Global Antimicrobial Susceptibility Testing Device Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Antimicrobial Susceptibility Testing Device Forecast by Type (2026-2031)
12.7 Global Antimicrobial Susceptibility Testing Device Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Q-Linea
13.1.1 Q-Linea Company Information
13.1.2 Q-Linea Antimicrobial Susceptibility Testing Device Product Portfolios and Specifications
13.1.3 Q-Linea Antimicrobial Susceptibility Testing Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Q-Linea Main Business Overview
13.1.5 Q-Linea Latest Developments
13.2 Liofilchem
13.2.1 Liofilchem Company Information
13.2.2 Liofilchem Antimicrobial Susceptibility Testing Device Product Portfolios and Specifications
13.2.3 Liofilchem Antimicrobial Susceptibility Testing Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Liofilchem Main Business Overview
13.2.5 Liofilchem Latest Developments
13.3 Beckman
13.3.1 Beckman Company Information
13.3.2 Beckman Antimicrobial Susceptibility Testing Device Product Portfolios and Specifications
13.3.3 Beckman Antimicrobial Susceptibility Testing Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Beckman Main Business Overview
13.3.5 Beckman Latest Developments
13.4 Thermo Fisher Scientific
13.4.1 Thermo Fisher Scientific Company Information
13.4.2 Thermo Fisher Scientific Antimicrobial Susceptibility Testing Device Product Portfolios and Specifications
13.4.3 Thermo Fisher Scientific Antimicrobial Susceptibility Testing Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Thermo Fisher Scientific Main Business Overview
13.4.5 Thermo Fisher Scientific Latest Developments
13.5 Biomerieux
13.5.1 Biomerieux Company Information
13.5.2 Biomerieux Antimicrobial Susceptibility Testing Device Product Portfolios and Specifications
13.5.3 Biomerieux Antimicrobial Susceptibility Testing Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Biomerieux Main Business Overview
13.5.5 Biomerieux Latest Developments
13.6 BD
13.6.1 BD Company Information
13.6.2 BD Antimicrobial Susceptibility Testing Device Product Portfolios and Specifications
13.6.3 BD Antimicrobial Susceptibility Testing Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 BD Main Business Overview
13.6.5 BD Latest Developments
13.7 Bio-Rad
13.7.1 Bio-Rad Company Information
13.7.2 Bio-Rad Antimicrobial Susceptibility Testing Device Product Portfolios and Specifications
13.7.3 Bio-Rad Antimicrobial Susceptibility Testing Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Bio-Rad Main Business Overview
13.7.5 Bio-Rad Latest Developments
13.8 Accelerate Diagnostics, Inc
13.8.1 Accelerate Diagnostics, Inc Company Information
13.8.2 Accelerate Diagnostics, Inc Antimicrobial Susceptibility Testing Device Product Portfolios and Specifications
13.8.3 Accelerate Diagnostics, Inc Antimicrobial Susceptibility Testing Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Accelerate Diagnostics, Inc Main Business Overview
13.8.5 Accelerate Diagnostics, Inc Latest Developments
13.9 Alifax
13.9.1 Alifax Company Information
13.9.2 Alifax Antimicrobial Susceptibility Testing Device Product Portfolios and Specifications
13.9.3 Alifax Antimicrobial Susceptibility Testing Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Alifax Main Business Overview
13.9.5 Alifax Latest Developments
13.10 Synbiosis
13.10.1 Synbiosis Company Information
13.10.2 Synbiosis Antimicrobial Susceptibility Testing Device Product Portfolios and Specifications
13.10.3 Synbiosis Antimicrobial Susceptibility Testing Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Synbiosis Main Business Overview
13.10.5 Synbiosis Latest Developments
14 Research Findings and Conclusion
*If Applicable.
